218 related articles for article (PubMed ID: 35078970)
1. Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence.
Zhou SL; Zhou ZJ; Song CL; Xin HY; Hu ZQ; Luo CB; Luo YJ; Li J; Dai Z; Yang XR; Shi YH; Wang Z; Huang XW; Fan J; Zhou J
Signal Transduct Target Ther; 2022 Jan; 7(1):24. PubMed ID: 35078970
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.
Kan Z; Zheng H; Liu X; Li S; Barber TD; Gong Z; Gao H; Hao K; Willard MD; Xu J; Hauptschein R; Rejto PA; Fernandez J; Wang G; Zhang Q; Wang B; Chen R; Wang J; Lee NP; Zhou W; Lin Z; Peng Z; Yi K; Chen S; Li L; Fan X; Yang J; Ye R; Ju J; Wang K; Estrella H; Deng S; Wei P; Qiu M; Wulur IH; Liu J; Ehsani ME; Zhang C; Loboda A; Sung WK; Aggarwal A; Poon RT; Fan ST; Wang J; Hardwick J; Reinhard C; Dai H; Li Y; Luk JM; Mao M
Genome Res; 2013 Sep; 23(9):1422-33. PubMed ID: 23788652
[TBL] [Abstract][Full Text] [Related]
3. Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing.
Duan M; Hao J; Cui S; Worthley DL; Zhang S; Wang Z; Shi J; Liu L; Wang X; Ke A; Cao Y; Xi R; Zhang X; Zhou J; Fan J; Li C; Gao Q
Cell Res; 2018 Mar; 28(3):359-373. PubMed ID: 29327728
[TBL] [Abstract][Full Text] [Related]
4. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC.
Rana MA; Ijaz B; Daud M; Tariq S; Nadeem T; Husnain T
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):373-386. PubMed ID: 30377095
[TBL] [Abstract][Full Text] [Related]
5. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
6. Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer.
Li CL; Ho MC; Lin YY; Tzeng ST; Chen YJ; Pai HY; Wang YC; Chen CL; Lee YH; Chen DS; Yeh SH; Chen PJ
Hepatology; 2020 Dec; 72(6):2063-2076. PubMed ID: 32171027
[TBL] [Abstract][Full Text] [Related]
7. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection.
Teng CF; Li TC; Huang HY; Chan WL; Wu HC; Shyu WC; Su IJ; Jeng LB
PLoS One; 2020; 15(11):e0242748. PubMed ID: 33237972
[TBL] [Abstract][Full Text] [Related]
9. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns.
Oropeza CE; Ondracek CR; Tarnow G; Maienschein-Cline M; Green SJ; McLachlan A
Virology; 2022 Jan; 566():16-25. PubMed ID: 34844082
[TBL] [Abstract][Full Text] [Related]
11. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
12. Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences.
Chen S; Huang C; Liao G; Sun H; Xie Y; Liao C; Wang J; He M; Hu H; Dai Z; Ren X; Zeng X; Lin Z; Zhang GP; Xie W; Shen S; Li S; Peng S; Kuang DM; Zhao Q; Duda DG; Kuang M
Gut; 2023 Jun; 72(6):1196-1210. PubMed ID: 36596711
[TBL] [Abstract][Full Text] [Related]
13. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
14. Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX.
Jiang Z; Liu H
J Cell Biochem; 2018 Jun; 119(6):4482-4495. PubMed ID: 29231260
[TBL] [Abstract][Full Text] [Related]
15. Association of Increased Programmed Death Ligand 1 Expression and Regulatory T Cells Infiltration with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection.
Jeng LB; Li TC; Hsu SC; Teng CF
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746817
[TBL] [Abstract][Full Text] [Related]
16. Deep whole-genome analysis of 494 hepatocellular carcinomas.
Chen L; Zhang C; Xue R; Liu M; Bai J; Bao J; Wang Y; Jiang N; Li Z; Wang W; Wang R; Zheng B; Yang A; Hu J; Liu K; Shen S; Zhang Y; Bai M; Wang Y; Zhu Y; Yang S; Gao Q; Gu J; Gao D; Wang XW; Nakagawa H; Zhang N; Wu L; Rozen SG; Bai F; Wang H
Nature; 2024 Mar; 627(8004):586-593. PubMed ID: 38355797
[TBL] [Abstract][Full Text] [Related]
17. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.
Su CW; Chiou YW; Tsai YH; Teng RD; Chau GY; Lei HJ; Hung HH; Huo TI; Wu JC
PLoS One; 2013; 8(6):e66457. PubMed ID: 23805222
[TBL] [Abstract][Full Text] [Related]
19. Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinoma.
Mani SKK; Yan B; Cui Z; Sun J; Utturkar S; Foca A; Fares N; Durantel D; Lanman N; Merle P; Kazemian M; Andrisani O
Theranostics; 2020; 10(24):10957-10972. PubMed ID: 33042264
[No Abstract] [Full Text] [Related]
20. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
